Search for Clinical Trials
ACCLAIM-Lp(a) is a clinical research study for people who have or are at risk for heart disease, stroke, or peripheral artery disease. Lipoprotein(a…
Around 1 in 5 people inherit raised levels of a sticky particle called Lp(a) (or lipoprotein(a)) that can lead to cardiovascular disease. So if…
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH (…
The purpose of this study is to evaluate the efficacy of an investigational drug on triglyceride level in patients with familial chylomicronemia…
The purpose of this study is to evaluate the efficacy and safety of an investigational drug in patients with severe hypertriglyceridemia.…
The purpose of this study is to evaluate the efficacy and safety of an investigational drug in patients with mixed dyslipidemia. Participants will…
Lp(a)HORIZON is an outcome study to determine whether treatment with an investigational drug reduces risk for major cardiovascular events in patients…
